Home » Newsletters » BioWorld Science

BioWorld Science

July 12, 2022

View Archived Issues

PLK4 inhibitor with promising preclinical activity against TRIM37-amplified breast cancer

Murine model resembles cardiovascular disease seen in NAFLD

Medshine Discovery patents compounds for fungal infections

Chiesi Farmaceutici discloses new ROCK inhibitors

UCB SA divulges new DRD1 PAMs

Roche presents new Raf kinase B inhibitors

Chengdu Baiyu Pharmaceutical identifies new LANCL2 activators

SBP-101 modulates polyamine metabolism and shows efficacy in ovarian cancer models

Novel murine models of diet-induced NASH developed

RS BioTherapeutics reports findings on RSBT-001 in mouse model of pulmonary inflammation

MIF/CD74 axis identified as a critical determinant of TME composition in sarcoma

iNtRON Biotechnology reports efficacy of CDL-200 against clinical isolates from CDI patients

PARP/SIK2 inhibition shows potential for treating ovarian cancer and TNBC

Tenaya sets out rationale for targeting HDAC6 in heart failure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...